The project that has been funded by the NIH for the last two years is facing a proposal that calls for new regulations dealing with nanomedicine. There haven’t been additional guidelines for research being done on nanomedicine, and it still falls under the guidelines as all other medicines and research when it comes to protecting humans involved in the research process. Nanomedicine is being heavily tested on human volunteers and is projected to be in mass production by 2020, so the team’s recommended guidelines are in anticipation of the change. To read more, go here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.